Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan versus nebivolol versus combination therapy for aortic root dilation progression in Marfan syndrome
2008-001462-81Phase 3Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Marfan syndrome (MFS) comparing Losartan, Nebivolol and Losartan + nebivolol (3 arms). Primary endpoint: Rate of progression of aortic root dilation. Started Mar 2008; status: terminated.
02
Drugs
losartannebivolol
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on 2008-001462-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001462-81.